SURF - This Is Why Surface Oncology Is a Great Stock to Buy Right Now
Buying a stock means taking a chance that you'll lose money, so that your money will have a chance to grow. Thankfully, it's not possible to lose more money than it costs to buy the shares in the first place, though it is possible to make far more than your initial investment. So, by seeding your portfolio with a few high-risk and high-reward stocks, you're increasing the chances of finding a disproportionately large winner that will make up for your losses.
Pre-product biotech stocks are excellent options for this kind of controlled speculation. In that vein, let's investigate Surface Oncology (NASDAQ: SURF) , which doesn't have any products on the market, nor does it have the prospect of consistent revenue on the horizon. So, how could it be a great stock to buy? Like many small biotechs, it's a company that could be worth ten times as much in 2031 compared to now, and that makes it worth paying attention to.
Image source: Getty Images.
For further details see:
This Is Why Surface Oncology Is a Great Stock to Buy Right Now